{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:55:17Z","timestamp":1792292117017,"version":"4.4.0"},"reference-count":19,"publisher":"AACN Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>INTRODUCTION<\/jats:title>\n                  <jats:p>Only a few cases of biventricular cardiogenic shock have been treated with Impella circulatory assist devices in the United States.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CLINICAL FINDINGS<\/jats:title>\n                  <jats:p>A 29-year-old man came to the emergency department because of cough, shortness of breath, fever, and chills. Initial assessment revealed hypotension; an elevated creatinine level of 2.1 mg\/dL; and markedly elevated results on liver function tests, with alanine transaminase 5228 IU\/L and aspartate aminotransferase 6200 IU\/L. The patient\u2019s signs and symptoms met criteria for New York Heart Association class IV heart failure and associated poor prognosis for recovery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DIAGNOSIS<\/jats:title>\n                  <jats:p>Echocardiography revealed dilated cardiomyopathy and biventricular failure with an ejection fraction of 15%. Results of an endomyocardial biopsy confirmed the diagnosis of myocarditis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>INTERVENTIONS<\/jats:title>\n                  <jats:p>After unsuccessful treatment with inotropes, biventricular support was started with an Impella CP device in the left ventricle and an Impella RP device in the pulmonary artery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>The patient was maintained on support for 8 days and was discharged to home from the hospital after 27 days. Repeat echocardiography 90 days after discharge indicated improvement in ejection fraction to 40%. At follow-up 16 weeks after discharge, all signs and symptoms of heart failure had resolved. The patient has not had any inpatient readmissions to the hospital to date.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>This case presents an opportunity for analysis of care activities and role responsibilities of bedside nurses in caring for this patient. Discussion of this case expands the literature describing nursing activities associated with caring for patients with Impella devices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.4037\/ccn2019477","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T09:15:13Z","timestamp":1554110113000},"page":"15-28","source":"Crossref","is-referenced-by-count":7,"title":["Percutaneous Biventricular Mechanical Heart Support in Cardiogenic Shock: A Nursing Case Report"],"prefix":"10.4037","volume":"39","author":[{"given":"Bridget K.","family":"Dittman","sequence":"first","affiliation":[{"name":"Bridget K. Dittman is a clinical nurse practice leader in the intensive care unit at Einstein Center Montgomery in East Norriton, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2471","reference":[{"issue":"6","key":"2019112515275633700_b1-0390015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ahj.2012.03.003","article-title":"Cardiogenic shock complicating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events","volume":"163","author":"Awad","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"2019112515275633700_b2-0390015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCOUTCOMES.115.002359","article-title":"Decade-long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction","volume":"9","author":"Goldberg","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"suppl 1","key":"2019112515275633700_b3-0390015","article-title":"Simultaneous, not staged, deployment of biventricular micro-axial flow Impella catheters (BiPella) is associated with improved survival for cardiogenic shock involving biventricular failure [abstract 19972]","volume":"134","author":"Kapur","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"2019112515275633700_b4-0390015","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1016\/j.healun.2016.01.789","article-title":"Biventricular Impella support: a contemporary approach to acute mechanical circulatory support for cardiogenic shock due to biventricular failure [abstract]","volume":"35","author":"Aghili","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"2019112515275633700_b5-0390015","first-page":"003636","article-title":"Biventricular circulatory support using 2 axial flow catheters for cardiogenic shock without the need for surgical vascular access","author":"Aghili","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"2019112515275633700_b6-0390015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ccd.26297","article-title":"A team-based approach to patients in cardiogenic shock","volume":"88","author":"Doll","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2019112515275633700_b7-0390015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1752-1947-7-223","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"7","author":"Gagnier","year":"2013","journal-title":"J Med Case Rep"},{"issue":"1","key":"2019112515275633700_b8-0390015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4037\/ccn2011293","article-title":"Use of the Impella 2.5 in high-risk percutaneous coronary intervention","volume":"31","author":"McCulloch","year":"2011","journal-title":"Crit Care Nurse"},{"issue":"1","key":"2019112515275633700_b9-0390015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-015-0063-y","article-title":"Experts\u2019 recommendations for the management of adult patients with cardiogenic shock [published correction appears in Ann Intensive Care. 2015;5(1):52]","volume":"5","author":"Levy","year":"2015","journal-title":"Ann Intensive Care"},{"issue":"3","key":"2019112515275633700_b10-0390015","first-page":"CD011582","article-title":"Vasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shock","author":"Unverzagt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2019112515275633700_b11-0390015","first-page":"CD007398","article-title":"Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock","author":"Unverzagt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2019112515275633700_b12-0390015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/joic.12172","article-title":"The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction","volume":"28","author":"Casassus","year":"2015","journal-title":"J Interv Cardiol"},{"issue":"1","key":"2019112515275633700_b13-0390015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.athoracsur.2013.07.053","article-title":"The Impella device for acute mechanical circulatory support in patients in cardiogenic shock","volume":"97","author":"Lemaire","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"2019112515275633700_b14-0390015","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1002\/ccd.25247","article-title":"Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: cost-effectiveness in the emergent setting","volume":"83","author":"Maini","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"2019112515275633700_b15-0390015","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1002\/ccd.25720","article-title":"2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie D\u2019intervention)","volume":"85","author":"Rihal","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2019112515275633700_b16-0390015","volume-title":"Impella Ventricular Support Systems for Use During Cardiogenic Shock and High Risk PCI: Impella 2.5, Impella 5.0, Impella LD, and Impella CP (SHOCK), Impella 2.5 and Impella CP (HRPCI): Instructions for Use and Clinical Reference Manual","year":"2016"},{"issue":"8 suppl","key":"2019112515275633700_b17-0390015","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.cardfail.2016.06.377","article-title":"Defining hemodynamic profiles and outcomes associated with cardiogenic shock and acute mechanical circulatory support [abstract 348]","volume":"22","author":"Esposito","year":"2016","journal-title":"J Card Failure"},{"issue":"6","key":"2019112515275633700_b18-0390015","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jacc.2010.08.613","article-title":"The percutaneous ventricular assist device in severe refractory cardiogenic shock","volume":"57","author":"Kar","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2019112515275633700_b19-0390015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2018.03.024","article-title":"Analysis of outcomes for 15 259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device","volume":"202","author":"O\u2019Neill","year":"2018","journal-title":"Am Heart J"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/39\/2\/15\/116915\/15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/39\/2\/15\/116915\/15.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T15:28:15Z","timestamp":1574695695000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/39\/2\/15\/63\/Percutaneous-Biventricular-Mechanical-Heart"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2019477","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}